2.325

1.09% 0.025

Pulmonx Corp (LUNG)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.30

Aprire:

$2.3

Volume 24 ore:

150.02K

Relative Volume:

0.26

Capitalizzazione di mercato:

$99.85M

Reddito:

$88.55M

Utile/perdita netta:

$-53.21M

Rapporto P/E:

-1.7969

EPS:

-1.2939

Flusso di cassa netto:

$-29.48M

1 W Prestazione:

-3.93%

1M Prestazione:

+83.07%

6M Prestazione:

+54.49%

1 anno Prestazione:

+51.96%

Intervallo 1D:

$2.23

$2.35

Intervallo di 1 settimana:

$2.165

$2.42

Portata 52W:

$1.13

$2.89

Pulmonx Corp Stock (LUNG) Company Profile

Nome

Pulmonx Corp

Settore

Healthcare (1087)

Industria

Medical Devices (140)

Telefono

650-364-0400

Indirizzo

700 CHESAPEAKE DRIVE, REDWOOD CITY

Dipendente

296

Cinguettio

Prossima data di guadagno

2026-07-29

Ultimi documenti SEC

LUNG's Discussions on Twitter

Compare LUNG vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LUNG Pulmonx Corp	2.325	99.21M	88.55M	-53.21M	-29.48M	-1.2939
ABT Abbott Laboratories	116.40	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.25	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	93.09	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	50.71	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.86	53.19B	6.30B	1.07B	1.09B	1.8406

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-31	Downgrade	Piper Sandler	Overweight → Neutral
2025-03-10	Iniziato	D. Boral Capital	Buy
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-06-04	Iniziato	Lake Street	Buy
2024-02-23	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-09-05	Iniziato	Craig Hallum	Buy
2023-02-27	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-01-03	Downgrade	BofA Securities	Neutral → Underperform
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-07-11	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Neutral
2021-12-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-04-01	Iniziato	Citigroup	Buy
2021-03-25	Iniziato	Piper Sandler	Neutral
2021-03-10	Aggiornamento	BofA Securities	Neutral → Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-10-26	Iniziato	BofA Securities	Buy
2020-10-26	Iniziato	Canaccord Genuity	Buy
2020-10-26	Iniziato	Morgan Stanley	Equal-Weight
2020-10-26	Iniziato	Stifel	Buy
2020-10-26	Iniziato	Wells Fargo	Equal Weight

Mostra tutto

Pulmonx Corp Borsa (LUNG) Ultime notizie

Aug 19, 2026

Pulmonx Corp (NASDAQ: LUNG) Share Price, LUNG Stock News, LUNG Share Price & Updates - Kalkine

Aug 19, 2026

Aug 15, 2026

Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year - MarketBeat

Aug 15, 2026

Aug 14, 2026

What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing - Stock Titan

Aug 13, 2026

Aug 11, 2026

Pulmonx at Canaccord Genuity growth conference: turnaround gains pace - Investing.com

Aug 11, 2026

Aug 07, 2026

Pulmonx (LUNG) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 07, 2026

Aug 04, 2026

Pulmonx Corp 2026: Revenue $22.76M, EPS ($0.24) — 10-Q Summary - TradingView

Aug 04, 2026

Aug 03, 2026

Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Aug 03, 2026

Aug 01, 2026

Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40 - Sahm

Aug 01, 2026

Jul 30, 2026

LUNG Looks 82.5% Undervalued on GF Value™ Despite Financial Chal - GuruFocus

Jul 30, 2026

Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG) - MarketBeat

Jul 30, 2026

Jul 29, 2026

Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4% - Investing.com

Jul 29, 2026